Table 3.

Commonly recommended therapeutic optionsfor human allergic rhinitis and asthma

	Allergic rhinitis 87,88,100,101,150	Asthma 97,151-154
✜ First-line/major treatment options	✜ Intranasal corticosteroids (eg, fluticasone, beclomethasone, mometasone, budesonide) ✜ Intranasal antihistamines (eg, azelastine, olopatadine) ✜ Oral second-generation antihistamines (eg, cetirizine, loratidine, desloratadine, bilastine, fexofenadine, levocetrizine)	✜ Inhaled corticosteroids (eg, fluticasone, budesonide, mometasone) ✜ Inhaled long-acting β-2 agonists (eg, salmeterol, formoterol) ✜ Inhaled short-acting β-2 agonists (eg, salbutamol, terbutaline)
✜ Second-line or adjuvant options	✜ Intranasal cromolyn ✜ Intranasal anticholinergics (eg, ipratropium) ✜ Leukotriene receptor antagonists	✜ Long-acting inhaled anticholinergics (eg, tiotropium) ✜ Antihistamines prior to exposure ✜ Leukotriene receptor antagonists ✜ Theophylline ✜ Anti-IgE antibodies ✜ Anti-IL-5 antibodies ✜ Anti-IL-5 receptor antibodies ✜ Anti-IL-4 antibodies